These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27106063)

  • 1. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic.
    Borecka M; Zemankova P; Vocka M; Soucek P; Soukupova J; Kleiblova P; Sevcik J; Kleibl Z; Janatova M
    Cancer Genet; 2016 May; 209(5):199-204. PubMed ID: 27106063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.
    Janatova M; Kleibl Z; Stribrna J; Panczak A; Vesela K; Zimovjanova M; Kleiblova P; Dundr P; Soukupova J; Pohlreich P
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2323-32. PubMed ID: 24136930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PALB2 as Another Candidate Gene for Genetic Testing in Patients with Hereditary Breast Cancer in Czech Republic].
    Janatová M; Borecká M; Soukupová J; Kleiblová P; Stříbrná J; Vočka M; Zemánková P; Panczak A; Veselá K; Souček P; Foretová L; Kleibl Z
    Klin Onkol; 2016; 29 Suppl 1():S31-4. PubMed ID: 26691940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
    Blanco A; de la Hoya M; Osorio A; Diez O; Miramar MD; Infante M; Martinez-Bouzas C; Torres A; Lasa A; Llort G; Brunet J; Graña B; Perez Segura P; Garcia MJ; Gutiérrez-Enríquez S; Carracedo Á; Tejada MI; Velasco EA; Calvo MT; Balmaña J; Benitez J; Caldés T; Vega A
    PLoS One; 2013; 8(7):e67538. PubMed ID: 23935836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline PALB2 mutation analysis in breast-pancreas cancer families.
    Stadler ZK; Salo-Mullen E; Sabbaghian N; Simon JA; Zhang L; Olson SH; Kurtz R; Offit K; Foulkes WD; Robson ME; Tischkowitz M
    J Med Genet; 2011 Aug; 48(8):523-5. PubMed ID: 21415078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The c.657del5 variant in the NBN gene predisposes to pancreatic cancer.
    Borecka M; Zemankova P; Lhota F; Soukupova J; Kleiblova P; Vocka M; Soucek P; Ticha I; Kleibl Z; Janatova M
    Gene; 2016 Aug; 587(2):169-72. PubMed ID: 27150568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EUS-based Pancreatic Cancer Surveillance in
    Katona BW; Long JM; Ahmad NA; Attalla S; Bradbury AR; Carpenter EL; Clark DF; Constantino G; Das KK; Domchek SM; Dudzik C; Ebrahimzadeh J; Ginsberg GG; Heiman J; Kochman ML; Maxwell KN; McKenna DB; Powers J; Shah PD; Wangensteen KJ; Rustgi AK
    Cancer Prev Res (Phila); 2021 Nov; 14(11):1033-1040. PubMed ID: 34341011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of PALB2 gene in French breast cancer families.
    Damiola F; Schultz I; Barjhoux L; Sornin V; Dondon MG; Eon-Marchais S; Marcou M; ; Caron O; Gauthier-Villars M; de Pauw A; Luporsi E; Berthet P; Delnatte C; Bonadona V; Maugard C; Pujol P; Lasset C; Longy M; Bignon YJ; Fricker JP; Andrieu N; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Muller D
    Breast Cancer Res Treat; 2015 Dec; 154(3):463-71. PubMed ID: 26564480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PALB2 mutations in familial breast and pancreatic cancer.
    Hofstatter EW; Domchek SM; Miron A; Garber J; Wang M; Componeschi K; Boghossian L; Miron PL; Nathanson KL; Tung N
    Fam Cancer; 2011 Jun; 10(2):225-31. PubMed ID: 21365267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PALB2 analysis in BRCA2-like families.
    Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H
    Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.
    Hellebrand H; Sutter C; Honisch E; Gross E; Wappenschmidt B; Schem C; Deissler H; Ditsch N; Gress V; Kiechle M; Bartram CR; Schmutzler RK; Niederacher D; Arnold N; Meindl A
    Hum Mutat; 2011 Jun; 32(6):E2176-88. PubMed ID: 21618343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer.
    Poumpouridou N; Goutas N; Tsionou C; Dimas K; Lianidou E; Kroupis C
    Fam Cancer; 2016 Apr; 15(2):183-91. PubMed ID: 26573693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation.
    Vietri MT; Caliendo G; Schiano C; Casamassimi A; Molinari AM; Napoli C; Cioffi M
    Fam Cancer; 2015 Sep; 14(3):341-8. PubMed ID: 25666743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel PALB2 truncating mutation in an Italian family with male breast cancer.
    Vietri MT; Caliendo G; Casamassimi A; Cioffi M; De Paola ML; Napoli C; Molinari AM
    Oncol Rep; 2015 Mar; 33(3):1243-7. PubMed ID: 25529982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry.
    Nguyen-Dumont T; Hammet F; Mahmoodi M; Tsimiklis H; Teo ZL; Li R; Pope BJ; Terry MB; Buys SS; Daly M; Hopper JL; Winship I; Goldgar DE; Park DJ; Southey MC
    Breast Cancer Res Treat; 2015 Jan; 149(2):547-54. PubMed ID: 25575445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer.
    Fernandes PH; Saam J; Peterson J; Hughes E; Kaldate R; Cummings S; Theisen A; Chen S; Trost J; Roa BB
    Cancer; 2014 Apr; 120(7):963-7. PubMed ID: 24415441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
    Jones S; Hruban RH; Kamiyama M; Borges M; Zhang X; Parsons DW; Lin JC; Palmisano E; Brune K; Jaffee EM; Iacobuzio-Donahue CA; Maitra A; Parmigiani G; Kern SE; Velculescu VE; Kinzler KW; Vogelstein B; Eshleman JR; Goggins M; Klein AP
    Science; 2009 Apr; 324(5924):217. PubMed ID: 19264984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.
    Connor AA; Denroche RE; Jang GH; Timms L; Kalimuthu SN; Selander I; McPherson T; Wilson GW; Chan-Seng-Yue MA; Borozan I; Ferretti V; Grant RC; Lungu IM; Costello E; Greenhalf W; Palmer D; Ghaneh P; Neoptolemos JP; Buchler M; Petersen G; Thayer S; Hollingsworth MA; Sherker A; Durocher D; Dhani N; Hedley D; Serra S; Pollett A; Roehrl MHA; Bavi P; Bartlett JMS; Cleary S; Wilson JM; Alexandrov LB; Moore M; Wouters BG; McPherson JD; Notta F; Stein LD; Gallinger S
    JAMA Oncol; 2017 Jun; 3(6):774-783. PubMed ID: 27768182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.
    Golan T; O'Kane GM; Denroche RE; Raitses-Gurevich M; Grant RC; Holter S; Wang Y; Zhang A; Jang GH; Stossel C; Atias D; Halperin S; Berger R; Glick Y; Park JP; Cuggia A; Williamson L; Wong HL; Schaeffer DF; Renouf DJ; Borgida A; Dodd A; Wilson JM; Fischer SE; Notta F; Knox JJ; Zogopoulos G; Gallinger S
    Gastroenterology; 2021 May; 160(6):2119-2132.e9. PubMed ID: 33524400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
    Holter S; Borgida A; Dodd A; Grant R; Semotiuk K; Hedley D; Dhani N; Narod S; Akbari M; Moore M; Gallinger S
    J Clin Oncol; 2015 Oct; 33(28):3124-9. PubMed ID: 25940717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.